November 5, 2019 Bio/Pharma/CRO Lab Top-10 Other Lab Products/Services

Thermo Fisher Scientific Highlights Expanded Pharma Services Capabilities During CPhI

Thermo Fisher Scientific Highlights Expanded Pharma Services Capabilities During CPhI Strategic investments support efforts to bring advanced medicines to market faster FRANKFURT, Germany, Nov. 5, 2019 /PRNewswire/ — CPhI 2019 — Thermo Fisher Scientific, the world leader in serving science, will highlight recent initiatives to expand its capabilities, capacity and talent globally at the 2019 CPhI Worldwide conference.... Read more

November 4, 2019 Bio/Pharma/CRO Licensing, IP, and Legal

SIEMENS HEALTHINEERS ENTERS INTO LICENSE AND SUPPLY ARRANGEMENT WITH QUANTERIX FOR ACCESS TO NEUROFILAMENT LIGHT (NF-L) ANTIBODIES TO DEVELOP NF-L ASSAYS

NOVEMBER 04, 2019 BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into a licensing and supply arrangement with Siemens Healthineers for access to Quanterix’ proprietary Nf-L antibodies, which were recently acquired from UmanDiagnostics. Access to the Nf-L antibodies will allow Siemens... Read more

November 4, 2019 Acad, Gov/Utilities Bio/Pharma/CRO

GE Healthcare announces U.S. FDA approval of macrocyclic MRI contrast agent Clariscan™ (gadoterate meglumine) injection for intravenous use

Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products  Chalfont St Giles, UK – November 4 2019 – The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast... Read more

October 28, 2019 Bio/Pharma/CRO Clinical Research/Diagn. Forensics & Security Microscopy Product Launch

Bruker Launches Ultrafast FTIR Imaging Microscope LUMOS II

ETTLINGEN, Germany, October 28, 2019 – Bruker today announced the launch of the novel, stand-alone FTIR (Fourier Transform Infrared) imaging microscope LUMOS II, which provides ultrafast FTIR imaging capabilities using focal-plane array (FPA) detectors in its high-end version. The new, automated LUMOS II is designed to identify particles, to determine coatings and contaminations, and to... Read more

October 22, 2019 Bio/Pharma/CRO Product Launch

MKS Announces Release of Ultra-Fast C-Series Mass Flow Controllers

Delivering ultra-fast response time for high precision flow control Andover, Mass., – October 22, 2019 – MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced the release of its next generation C-Series Mass Flow Controllers. C-Series Ultrafast Mass Flow Controller The C-Series Mass Flow Controller uses... Read more

October 21, 2019 Bio/Pharma/CRO Environ, Ag./Food & Bev Lab Top-10 M&A, Partnerships

Danaher Reaches Agreement To Sell Certain Businesses To Sartorius AG As Part Of The GE Biopharma Acquisition Regulatory Process

Danaher Reaches Agreement To Sell Certain Businesses To Sartorius AG As Part Of The GE Biopharma Acquisition Regulatory Process WASHINGTON, Oct. 21, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced that it has signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses to... Read more

October 18, 2019 Acad, Gov/Utilities Bio/Pharma/CRO

Roche announces FDA approval of Xofluza (baloxavir marboxil) for people at high risk of developing influenza-related complications

Basel, 18 October 2019 Roche announces FDA approval of Xofluza (baloxavir marboxil) for people at high risk of developing influenza-related complications Single-dose Xofluza is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from influenza (flu) The Centers for Disease Control and Prevention (CDC) defines people at... Read more

October 14, 2019 Bio/Pharma/CRO Molecular Spectroscopy Product Launch

New Handheld X-Ray Fluorescence Analyzer for Pharmaceutical Manufacturers Identifies Ionic Salt Raw Material in Seconds

New Handheld X-Ray Fluorescence Analyzer for Pharmaceutical Manufacturers Identifies Ionic Salt Raw Material in Seconds Thermo Scientific IonicX analyzer provides fast verification of ionic salts in the warehouse, saving time and money spent on lab-based wet chemistry or benchtop NIR testing TEWKSBURY, Mass., Oct. 14, 2019 /PRNewswire/ — Pharmaceutical and biopharmaceutical manufacturers can now verify... Read more

October 14, 2019 Bio/Pharma/CRO PR/Corporate

Phase III PEMPHIX study shows Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris

Basel, 14 October 2019 Phase III PEMPHIX study shows Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris 40% of patients with pemphigus vulgaris (PV) achieved sustained complete remission, without the use of steroids for 16 weeks or more, when treated with MabThera/Rituxan compared to 9.5% of patients on mycophenolate mofetil Study... Read more

October 7, 2019 Bio/Pharma/CRO M&A, Partnerships PR/Corporate

vertX Bioprocess Conference Convenes Biotech and Biopharma Leaders to Accelerate Industry Collaboration

vertX Bioprocess Conference Convenes Biotech and Biopharma Leaders to Accelerate Industry Collaboration Thermo Fisher Scientific’s forum focuses on strategies to expedite biotherapeutic development and commercialization LOGAN, Utah, Oct. 7, 2019 /PRNewswire/ — To discuss the future strategies of biologics development and commercialization, Thermo Fisher Scientific hosted the inaugural vertX Bioprocess Conference on Thursday, September 26... Read more